AKT1, a core mediator of the PI3K/AKT/mTOR pathway, contributes to BDS pathogenesis by balancing pro-/anti-inflammatory responses and metabolic reprogramming. This evidence concerns the gene AKT1 and Diamond-Blackfan anemia.